Use

This panel analyzes genes that are associated with predisposition to adult-onset breast cancer and provides medically actionable, evidence-based management and risk-reduction options. It guides cancer screening and risk-reduction measures, defining the age and intervals of screenings, preventive options, and the risk for subsequent primary cancers. Such measures may prevent cancer or lead to earlier diagnosis, thus increasing the chances of successful treatment and survival. The test covers a broad panel of genes to efficiently evaluate several potential genetic indicators based on a single clinical indication.